Condition
Obstructive Hypertrophic Cardiomyopathy clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Obstructive Hypertrophic Cardiomyopathy clinical trials that are recruiting, at sites in 10 countries (most in United States (3), Austria (1), Czechia (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 10Countries
Newest Obstructive Hypertrophic Cardiomyopathy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Assessing health changes in patients with obstructive hypertrophic cardiomyopathy treated with mavacamten | — | Boston, Massachusetts | Recruiting | Aug 13, 2024 |
| Assessing the safety of mavacamten in Korean patients with obstructive hypertrophic cardiomyopathy | — | Seoul and 1 other locations | Recruiting | Nov 27, 2023 |
| Effect of mavacamten on heart blood flow in obstructive hypertrophic cardiomyopathy | — | Charlottesville, Virginia | Recruiting | Sep 5, 2023 |
| Registry to assess patient characteristics and outcomes in obstructive hypertrophic cardiomyopathy | — | Anchorage, Alaska and 100 other locations | Recruiting | Aug 5, 2022 |
All recruiting trials (4)
-
Assessing health changes in patients with obstructive hypertrophic cardiomyopathy treated with mavacamten
This study is testing how well the medication mavacamten helps adults with obstructive hypertrophic cardiomyopathy feel and do better in their everyday lives.
-
Assessing the safety of mavacamten in Korean patients with obstructive hypertrophic cardiomyopathy
This study is testing how safe the medication mavacamten is for adults in Korea who have symptoms of obstructive hypertrophic cardiomyopathy.
-
Effect of mavacamten on heart blood flow in obstructive hypertrophic cardiomyopathy
This study is testing if the medication mavacamten can improve blood flow in the hearts of people with obstructive hypertrophic cardiomyopathy after a year of treatment.
-
Registry to assess patient characteristics and outcomes in obstructive hypertrophic cardiomyopathy
This study is trying to learn more about how people with obstructive hypertrophic cardiomyopathy are treated and what their experiences are, especially for those using the medication mavacamten.
Quick answers
How many Obstructive Hypertrophic Cardiomyopathy clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in United States (3 trials), Austria (1 trial), Czechia (1 trial), France (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.